NEJM April 9, 2021
Deidra C. Crews, MD, ScM, Precious McCowan, MS & Tonya Saffer, MPH

Care for end-stage kidney disease, which disproportionately affects people of color, has been predominantly delivered in dialysis centers, even when home dialysis would offer the same benefits with less cost and more convenience for the patients. The Covid-19 pandemic made the expansion of home care essential for many diseases. The authors explore how to preserve and expand home care for dialysis patients with regulatory changes and better coordination among programs.

Summary

The Covid-19 pandemic has posed particular risks to people with end-stage kidney disease, not only from Covid-19 infection, but also from disrupting dialysis center operations and limiting access to transplantation and other surgical procedures. ESKD...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Healthcare System, HHS, Home, Insurance, Medicare, Patient / Consumer, Provider, Public Health / COVID
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
FDA launches initiative to advance home healthcare models, devices
Novant Health launches 'hospital at home' with $2.7M donation
FDA initiative puts AR/VR at heart of home health drive
Understanding the Value of the Home as a Healthcare Site

Share This Article